|
Date
|
Event
|
|---|---|
|
March 5th, 2025 |
Review and approval of the results for the financial year ended 31 December 2024 Analysts conference call |
|
April 9th, 2025 |
Review and approval of the annual report for the financial year ended 31 December 2024
|
|
May 7th, 2025 |
Review and approval of the additional periodic financial information* for the period ended 31 March 2025 Analysts conference call |
|
June 3rd, 2025 |
Annual general meeting for the adoption of the financial statements for the financial year ended 31 December 2024
|
|
July 31th, 2025 |
Review and approval of the 2025 half-year report Analysts conference call
|
|
November 5th, 2025 |
Review and approval of the additional periodic financial information* for the period ended 30 September 2025 Analysts conference call |
* Additional periodic financial information consists in: Revenue by division, Adjusted EBITDA, Adjusted EBIT, EBITDA, EBIT, Operating cash flow, Profit before tax.
The potential payment of the dividend related to the 2024 results will happen in the month of June 2025.